Skye Bioscience, Inc. (SKYE) stock
SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$1.03+0.03 (+3.00%)
Close on Nov 18, 2026Market cap $36.48MP/E –Yield –
Skye Bioscience revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for Skye Bioscience
Skye Bioscience has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?